IP Library Granted Patent US 7,009,078
Granted Patent B1
US 7,009,078 · App. 10/048,229 · Granted Mar 7, 2006

Production of N-substituted 2,7-dialkyl-4-hydroxy-5-amino-8-arly-octanoylamides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,009,078
App. No.
10/048,229
Granted
Mar 7, 2006
Kind
B1
Abstract

From compounds of formula II wherein R 1 and R 2 are independently of one another H, C 1 –C 6 alkyl, C 1 –C 6 halogenalkyl, C 1 –C 6 alkoxy, C 1 –C 6 alkoxy-C 1 –C 6 alkyl, or C 1 –C 6 alkoxy-C 1 –C 6 alkyloxy, R 3 is C 1 –C 6 alkyl, R 4 is C 1 –C 6 alkyl, and R 5 is C 1 –C 6 alkyl, C 1 –C 6 hydroxyalkyl, C 1 –C 6 alkoxy-C 1 –C 6 -alkyl, C 1 –C 6 alkanoyloxy-C 1 –C 6 alkyl, C 1 –C 6 aminoalkyl, C 1 –C 6 alkylamino-C 1 –C 6 -alkyl, C 1 –C 6 -dialkylamino-C 1 –C 6 -alkyl, C 1 –C 6 -alkanoylamido-C 1 –C 6 -alkyl, HO(O)C—C 1 –C 6 -alkyl, C 1 –C 6 alkyl-O—(O)C—C 1 –C 6 alkyl, H 2 N—C(O)—C 1 –C 6 alkyl, C 1 –C 6 alkyl-HN—C(O)—C 1 –C 6 alkyl or (C 1 –C 6 alkyl) 2 N—C(O)—C 1 –C 6 -alkyl, R 6 is C 1 –C 6 alkyl, R 7 is C 1 –C 6 alkyl or C 1 –C 6 alkoxy, or R 6 and R 7 together are tetramethylene, pentamethylene, 3-oxa-1,5-pentylene or —CH 2 CH 2 O— substituted, if necessary, with C 1 –C 4 -Alkyl, phenyl or benzyl, it is possible—through halolactonization, azidation of the halogen group, ring opening with an amine R 5 —NH 2 , and reduction of the azide group to form the amino group—to prepare compounds of formula I wherein R 5 is C 1 –C 6 alkyl, C 1 –C 6 hydroxyalkyl, C 1 –C 6 alkoxy-C 1 –C 6 alkyl, C 1 –C 6 alkanoyloxy-C 1 –C 6 alkyl, C 1 –C 6 aminoalkyl, C 1 –C 6 alkylamino-C 1 –C 6 alkyl, C 1 –C 6 dialkylamino-C 1 –C 6 -alkyl, C 1 –C 6 alkanoylamido-C 1 –C 6 alkyl, HO(O)C—C 1 –C 6 alkyl, C 1 –C 6 alkyl-O—(O)C—C 1 –C 6 alkyl, H 2 N—C(O)—C 1 –C 6 alkyl, C 1 –C 6 alkyl-HN—C(O)—C 1 –C 6 alkyl or (C 1 –C 6 alkyl) 2 —N—C(O)—C 1 –C 6 alkyl. If 2(S), 7(R)-diastereomer of formula II is used, the 2(S), 4(S), 5(S), 7(S)-diastereomer of formula Ia is obtained in a high degree of purity.

Claims (27)

1. Process for preparation of compounds of formula I,

wherein

R 1 and R 2 are independently of one another H, C 1 –C 6 alkyl, C 1 –C 6 halogenalkyl, C 1 –C 6 alkoxy, C 1 –C 6 alkoxy-C 1 –C 6 alkyl, or C 1 –C 6 alkoxy-C 1 –C 6 alkyloxy, R 3 is C 1 –C 6 alkyl, R 4 is C 1 –C 6 alkyl, and R 5 is C 1 –C 6 alkyl, C 1 –C 6 hydroxyalkyl, C 1 –C 6 alkoxy-C 1 –C 6 -alkyl, C 1 –C 6 alkanoyloxy-C 1 –C 6 alkyl, C 1 –C 6 aminoalkyl, C 1 –C 6 alkylamino-C 1 –C 6 -alkyl, C 1 –C 6 -dialkylamino-C 1 –C 6 -alkyl, C 1 –C 6 -alkanoylamido-C 1 –C 6 -alkyl, HO(O)C—C 1 –C 6 -alkyl, C 1 –C 6 alkyl-O—(O)C—C 1 –C 6 alkyl, H 2 N—C(O)—C 1 –C 6 alkyl, C 1 –C 6 alkyl-HN—C(O)—C 1 –C 6 alkyl or (C 1 –C 6 alkyl) 2 N—C(O)—C 1 –C 6 -alkyl, comprising

a) the reaction of a compound of formula II

wherein

R 6 is C 1 –C 6 alkyl, R 7 is C 1 –C 6 alkyl or C 1 –C 6 alkoxy, or R 6 and R 7 together are tetramethylene, pentamethylene, 3-oxa-1,5-pentylene or —CH 2 CH 2 O—C(O)— optionally substituted with C 1 –C 4 alkyl, phenyl or benzyl, with a halogenation agent in the presence of water, and optionally, an acid to form a compound of formula III,

wherein X is Cl, Br or I,

b) reaction of the compound of formula III with an azidation agent to form a compound of formula IV,

c) thereafter reaction of the compound of formula IV with an amine of formula R 5 —NH 2 to form a compound of formula V,

and

d) for preparation of a compound of formula I, reduction of the azide group of the compound of formula V to form the amine group and then isolation of the compounds of formula I, optionally with the addition of a salt-forming acid.

2. A process according to claim 1 wherein R 1 is C 1 –C 4 alkoxy or C 1 –C 4 alkoxy-C 1 –C 4 alkyloxy, R 2 is C 1 –C 4 alkoxy, R 3 is C 1 –C 4 alkyl, R 4 is C 1 –C 4 alkyl and R 5 is H 2 NC(O)—C 1 –C 6 alkyl which optionally is N-monosubstituted or N-di-C 1 –C 4 alkyl substituted.

3. A process according to claim 2 wherein R 1 is 1-methoxyprop-3-yloxy and R 2 is methoxy.

4. A process according to claim 2 wherein R 3 and R 4 are in each case isopropyl.

5. A process according to claim 2 wherein R 5 is H 2 NC(O)—C 1 –C 6 alkyl.

6. A process according to claim 1 wherein R 1 is methoxy-C 2 –C 4 alkyloxy, R 2 is methoxy or ethoxy, R 3 is C 2 –C 4 alkyl, R 4 is C 2 –C 4 alkyl and R 5 is H 2 NC(O)—C 1 –C 6 alkyl.

7. A process according to claim 1 wherein R 1 is 3-methoxy-prop-3-yloxy, R 2 is methoxy, R 3 and R 4 are 1-methyleth-1-yl, and R 5 is H 2 NC(O)-[C(CH 3 ) 2 ]—CH 2 —.

8. A process according to any one of claims 1 to 7 comprising the preparation of diastereomers of formula Ia

by

a) the reaction of a compound of formula IIa

with a halogenation agent in the presence of water and optionally an acid to form a compound of formula IIIa,

wherein X is Cl, Br or I,

b) reaction of the compound of formula IIIa with an azidation agent to form a compound of formula IVa,

c) then reaction of the compound of formula IVa with an amine of formula R 5 —NH 2 to form a compound of formula Va,

and

d) for preparation of a compound of formula I, reduction of the azide group of the compound of formula Va to form the amine group and then isolation of the compounds of formula Ia, optionally with the addition of a salt-forming acid.

9. A process according to claim 8 , wherein R 1 is CH 3 O—(CH 2 ) 3 —O—, R 2 is CH 3 O—, R 3 and R 4 are in each case 1-methylethyl, and R 5 is —CH 2 —(CCH 3 ) 2 —C(O)—NH 2 .

Assignments (4)
CHANGE OF ADDRESS Recorded Mar 21, 2017
From: NODEN PHARMA DAC
To: NODEN PHARMA DAC
Reel/Frame 042084/0980 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 039481 FRAME 0233. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 29, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 040003/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2016
From: NOVARTIS AG; NOVARTIS PHARMA AG; SPEEDEL HOLDING AG
To: NODEN PHARMA DAC
Reel/Frame 039481/0233 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2005
From: HEROLD, PETER; STUTZ, STEFAN; INDOLESE, ADRIANO
To: SPEEDEL PHARMA AG
Reel/Frame 017120/0712 →